Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings

John Readman, Joseph F. Standing, Adnan M. H. Hamawandi et al.|Journal of Antimicrobial Chemotherapy|2023

Cited by 7